We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The European Investment Bank (EIB) has granted a €120m loan to Spanish pharmaceutical company Almirall to support its research, development and innovation (RDI) activities related to skin healthcare therapeutic products.